Cloud Banner

Pharmaceutical

Image

Global Needle Biopsy Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Feb 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Needle Biopsy Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR - 6.6000000000000005% Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 1220.57 Million
Diagram Market Size (Forecast Year) USD 2035.26 Million
Diagram CAGR 6.6000000000000005%

Global Needle Biopsy Market, By Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Product (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy, Needle Based Biopsy Guns, Biopsy Needles), Procedure (Image-guided Procedures, Ultrasound-guided Procedures, Stereotactic Procedures, CT-guided Procedures, MRI-guided Procedures, and Other Procedures), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour/Cancer, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2031.

 

Needle Biopsy Market Analysis and Size

In Europe, with breast cancer cases projected to rise from 531,000 in 2020 to 568,000 by 2040, needle biopsy procedures play a crucial role in early diagnosis. As the most prevalent cancer type, needle biopsies aid in early and accurate diagnosis, guiding treatment decisions. The increasing incidence underscores the pivotal role of needle biopsy technologies in breast cancer management.               

Data Bridge Market Research analyses that the global needle biopsy market which was USD 125.51 million in 2023, is expected to reach USD 174.43 million by 2031, and is expected to undergo a CAGR of 4.2% during the forecast period of 2024 to 2031. This indicates that the market value. “Fine-needle aspiration biopsy” is expected to dominate the procedure segment of the needle biopsy market due to its minimally invasive nature. This technique allows for precise tissue sampling with minimal patient discomfort and rapid recovery. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Needle Biopsy Market Scope and Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Needle Type (Trephine Biopsy Needles, Klima Sternal Needle, Salah Needle Aspiration Needle, Jamshidi Needle and Others), Ergonomics (Sharp, Blunt, Quincke, Chiba, Franseen and Others), Product (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy, Needle Based Biopsy Guns, Biopsy Needles), Procedure (Image-guided Procedures, Ultrasound-guided Procedures, Stereotactic Procedures, CT-guided Procedures, MRI-guided Procedures, and Other Procedures), Sample Site (Muscles, Bones and Other Organs), Utility (Disposable and Reusable), Application (Tumour/Cancer, Infection, Inflammation and Others), End User (Hospitals, Diagnostic Centres, Biopsy Labs, Ambulatory Surgical Centres, Academic and Research Organizations and Others), Distribution Channel (Direct Tender, Retail Sales)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Medax  (Italy), Boston Scientific Corporation (U.S.) Cook Group (U.S.) Hologic, Inc. (U.S.), ST. STONE MEDICAL DEVICES PVT. LTD. (India), AprioMed AB (Sweden), AMECATH (Egypt), ZAMAR CARE. (Croatia), Cardinal Health (U.S.), INRAD, Inc. (U.S.), BD (U.S.), MÖLLER Medical GmbH (Germany), HAKKO CO.,LTD. (Japan), Argon Medical Devices (U.S.), Merit Medical Systems. (U.S.), weLLgo Medical Products GmbH (Germany), Swastik Enterprise (India), Tsunami Medical (Italy), PAJUNK (Germany) and B. Braun SE (Germany)

Market Opportunities

  • Rising Geriatric Population Escalating Demand for Diagnostic Tools
  • Minimally Invasive Procedures  Enhancing Accessibility

Market Definition

Needle biopsy is a minimally invasive procedure crucial for diagnostic tissue sampling. Utilizing a thin, hollow needle, it extracts samples from suspicious areas, aiding in the diagnosis of conditions such as cancer. Variants include fine-needle aspiration, core needle, and vacuum-assisted biopsies. This effective diagnostic tool ensures quicker recovery and reduced complications compared to traditional surgical biopsies.            

Global Needle Biopsy Market Dynamics

Drivers

  • Rising Cancer Screening and Early Detection

Needle biopsies play a crucial role in cancer screening and early detection by identifying genetic mutations through a blood test. This non-invasive approach allows for the detection of cancer in its early stages, enhancing the chances of successful treatment and improving patient outcomes.

  • Expanding Applications in Various Medical Specialties

Needle biopsy procedures, once primarily associated with oncology, are diversifying into broader medical applications. Their utility extends to infectious diseases and inflammatory conditions, marking a paradigm shift in diagnostic versatility. This expansion into various medical specialties propels the growth of the needle biopsy market, addressing a broader spectrum of diagnostic needs beyond traditional oncological applications.

Opportunities

  • Rising Geriatric Population  Escalating Demand for Diagnostic Tools

The growing geriatric population, with an increased susceptibility to various cancers, is a pivotal opportunity for the needle biopsy market. This demographic shift highlights a substantial opportunity in oncological diagnostics. Needle biopsies, vital for precise and minimally invasive cancer diagnosis, cater to the escalating demand for effective diagnostic tools, particularly in addressing the healthcare needs of the elderly.

  • Minimally Invasive Procedures  Enhancing Accessibility

The surge in minimally invasive procedures fuels the adoption of needle biopsies, driven by their advantages of minimizing patient discomfort, shortening recovery periods, and enhancing accessibility across diverse clinical applications. This trend aligns with the evolving healthcare landscape, emphasizing patient-centric approaches and contributing to the widespread acceptance of needle biopsy techniques.

Restraints/Challenges

  • Regulatory Compliance for Healthcare Providers

Navigating stringent regulatory requirements and staying updated on evolving standards pose significant challenges for manufacturers and healthcare providers in the needle biopsy market. Ensuring compliance demands continuous efforts and resources, impacting market dynamics and the development of needle biopsy technologies. The market faces a substantial challenge in meeting and adapting to these regulatory complexities. 

  • High Equipment Costs  Limits Accessibility

High equipment costs in needle biopsy procedures present financial hindrance for healthcare facilities, limiting accessibility and hindering widespread adoption. The financial burden associated with acquiring and maintaining necessary equipment impedes market growth, impacting both the market's expansion and overall healthcare accessibility for patients in need of these crucial diagnostic procedures.

This global needle biopsy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global needle biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In May 2022, Limaca Medical secured FDA breakthrough device status for its Precision-GI endoscopic ultrasound biopsy needle. This innovative, automated rotational cutting needle is designed to minimize issues such as tissue fragmentation, insufficient sample quantity, and blood contamination during biopsies
  • In January 2021, Hologic, Inc. acquired SOMATEX Medical Technologies GmbH for $64 million, increasing its breast cancer treatment offerings. The acquisition enhances Hologic's capability to offer diverse solutions for breast cancer, particularly through expanding its portfolio of biopsy site biomarkers
  • In August 2020, Hologic Inc innovated the Brevera Breast Needle Biopsy System with CorLumina Imaging Technology. The CorLumina Imaging Technology, incorporates vacuum-assisted tissue acquisition, real-time imaging verification and advanced post-biopsy handling in one integrated system
  • In February 2020, Moller Möller Medical GmbH launched the diagnostic product application of full-sCore technology for biopsies. The sCore Technology in needle biopsies consists of the well-adjusted crown cut core, which ensures less traumatic puncture and accurate diagnosis and collection of tissue. An echogenic distal tip ensures superb visibility under ultrasound-guided biopsy

Global Needle Biopsy Market Scope

The global needle biopsy market is segmented on the basis of the needle type, ergonomics, product, procedure, sample site, utility, application, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Needle Type

  • Trephine Biopsy Needles
  • Klima Sternal Needle
  • Salah Needle Aspiration Needle
  • Jamshidi Needle
  • Others

 Ergonomics

  • Sharp
  • Blunt
  • Quincke
  • Chiba
  • Franseen
  • Others

Product

  • Fine-Needle Aspiration Biopsy
  • Core Needle Biopsy
  • Vacuum-Assisted Biopsy
  • Image-Guided Biopsy
  • Needle Based Biopsy Guns
  • Biopsy Needles

 Procedure

  • Image-Guided Procedures
  • Ultrasound-Guided Procedures
  • Stereotactic Procedures
  • CT-Guided Procedures
  • MRI-Guided Procedures
  • Other Procedures

 Sample Site

  • Muscles
  • Bones
  • Other Organs

 Utility

  • Disposable
  • Reusable

 Application

  • Tumour/Cancer
  • Breast
  •  Lung
  •  Prostate
  •  Colon
  •  Stomach
  •  Liver
  •  Cervix Uteri
  • Thyroid
  • Infection
  • Inflammation
  • Others

 End User

  • Hospitals
  • Diagnostic Centres
  • Biopsy Labs
  •  Ambulatory Surgical Centres
  • Academic and Research Organizations
  • Others

 Distribution Channel

  • Direct Tender
  • Retail Sales

Global Needle Biopsy Market Regional Analysis/Insights

The global needle biopsy market is analysed and market size insights and trends are provided by country, needle type, ergonomics, product, procedure, sample site, utility, application, end user and distribution channel as referenced above.

The countries covered in the global needle biopsy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to dominate the global needle biopsy market, driven by its extensive consumer base and a high GDP. The U.S. takes the forefront, benefitting from FDA approvals, technological advancements, and a surge in clinical trials. The fine-needle aspiration biopsy segment dominates, offering cost-effective and accurate treatment, particularly in addressing rising breast cancer cases and an aging population.

Europe is expected to dominate the needle biopsy market, driven by untapped opportunities in Germany and the presence of leading cancer research institutes. Within this landscape, the fine-needle aspiration biopsy segment is poised for dominance, fueled by growing preference for minimally invasive procedures.

Asia-Pacific is expected to grow with the highest CAGR in the global needle biopsy market from 2024 to 2031. China is anticipated to dominate, driven by heightened cancer awareness, favorable reimbursement, and improved healthcare infrastructure. The fine-needle aspiration biopsy segment is expected to lead, supported by collaborations between healthcare entities and market players in China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The global needle biopsy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global needle biopsy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global needle biopsy market. The data is available for historic period 2016-2021.

Competitive Landscape and Global Needle Biopsy Market Share Analysis

The global needle biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global needle biopsy market.

Some of the major players operating in the global needle biopsy market are:

  • Medax  (Italy)
  • Boston Scientific Corporation (U.S.)
  • Cook Group (U.S.)
  •  Hologic, Inc. (U.S.)
  •  ST. STONE MEDICAL DEVICES PVT. LTD. (India)
  •  AprioMed AB (Sweden)
  •  AMECATH (Egypt)
  •  ZAMAR CARE. (Croatia)
  •  Cardinal Health (U.S.)
  •  INRAD, Inc. (U.S.)
  •  BD (U.S.)
  •  MÖLLER Medical GmbH (Germany)
  • HAKKO CO.,LTD. (Japan)
  •  Argon Medical Devices (U.S.)
  •  Merit Medical Systems. (U.S.)
  •  weLLgo Medical Products GmbH (Germany)
  •  Swastik Enterprise (India)
  •  Tsunami Medical (Italy)
  •  PAJUNK (Germany)
  • B. Braun SE (Germany)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The needle biopsy market size will be worth USD 2,035.26 million by 2031.
The growth rate of the needle biopsy market is 4.2% during the forecast by 2031.
Rising cancer screening and early detection & expanding applications in various medical specialties are the growth drivers of the needle biopsy market.
needle type, ergonomics, product, procedure, sample site, utility, application, end user and distribution channel are the factors on which the needle biopsy market research is based.
Major companies in the needle biopsy market are Medax (Italy), Boston Scientific Corporation (U.S.) Cook Group (U.S.) Hologic, Inc. (U.S.), ST. STONE MEDICAL DEVICES PVT. LTD. (India), AprioMed AB (Sweden), AMECATH (Egypt), ZAMAR CARE. (Croatia), Cardinal Health (U.S.), INRAD, Inc. (U.S.), BD (U.S.), MÖLLER Medical GmbH (Germany), HAKKO CO.,LTD. (Japan), Argon Medical Devices (U.S.), Merit Medical Systems. (U.S.), weLLgo Medical Products GmbH (Germany), Swastik Enterprise (India), Tsunami Medical (Italy), PAJUNK (Germany) and B. Braun SE (Germany).
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials